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Impaired vascular endothelium-dependent relaxa-
tion and augmented contractile responses have been
reported in several models of long-term hypergly-
cemia. However, the effects of short-term ambient
hyperglycemia are poorly understood. Since oxida-
tive stress has been implicated as a contributor to
impaired vascular function, we investigated the
following:
Aims: (1) the effects of high glucose exposure in
vitro (7-10 days) on vascular relaxation to acetylcho-
line (Ach) and contractility to norepinephrine (NE)
and KC1; (2) if NO-dependent cGMP generation is
affected under these conditions; and (3) aortic redox
status.
Methods: Non-diabetic rat tail artery rings were
incubated in normal (5mM) (control NG) or high
(20mM) glucose buffer (control HG). Vascular re-
sponses to Ach, NE and KC1 were compared to
those of streptozotocin (SZ) diabetic animals in
the same buffers (diabetic NG, diabetic HG). Ach-
stimulated cGMP levels were quantitated as an in-
direct assessment of endothelial nitric oxide (NO)
production and oxidative stress evaluated by
measuring vascular glutathione and oxidized
glutathione.
Results: Rings from diabetic rats in NG showed
impaired relaxation to Ach (P=0.002) but relaxed
normally, when maintained in HG. Similarly, con-
tractile responses to NE were attenuated in diabetic
rings in NG but similar to controls in HG. HG
markedly augmented maximal contraction to KC1
compared to control and diabetic vessels in NG
(P < 0.0001). Diabetic vessels in a hyperosmolar, but
normoglycemic, milieu respond like those in HG.
In vitro, HG for 2hours changed neither relaxation
nor contractile responses to NE and KC1 in control
rings. Basal cGMP levels were lower in aortae
from diabetic animals pre-incubated in NG than in
HG/LG or in control rings in NG (P <0.05). cGMP
responses to Ach were exaggerated in diabetic ves-
sels in HG (P=0.035 vs. control NG, P=0.043 vs.
diabetic NG) but not different between control
and diabetic rings in NG. Vessels from diabetic
animals had lower levels of GISH (P<0.0001) and
higher levels of GSSG (P< 0.0001) indicating oxida-
tive stress.
Conclusions: Our data indicate that endothelium-
dependent relaxation is altered early in the diabetic
state and that increased NO responses may com-
pensate for augmented oxidative stress but the lack
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of effect of short-term exposure of normal vessels to
HG suggests that short-term hyperglycemia per se
does not cause abnormal vascular responses.
Keywords: Hyperglycemia, cyclic GMP, endothelium, vascu-
lar, streptozocin, rats
INTRODUCTION
Hyperglycemia-induced alterations in vascular
endothelium and/or vascular smooth muscle
(VSM) metabolism are thought to mediate
many of the changes in vascular tone seen in
both human (Johnstone et al., 1993) and animal
diabetic states (Kamata et al., 1989; Durante
et al., 1988; Graier et al., 1993, 1996). However,
current information on vascular tone in diabetes
is largely derived from long-term animal models
where irreversible arterial wall changes such
as glycation and collagen deposition (Ruderman
et al., 1992) may contribute to endothelial and/
or VSM dysfunction (Poston and Taylor, 1995).
Indeed, in human disease, impairment of en-
dothelium-dependent relaxation does not corre-
late with glycemic control (Johnstone et al., 1993)
and normal vascular relaxation to acetylcholine
(Ach) has been reported in uncomplicated type
2 diabetes mellitus (Avogaro et al., 1997). Also,
in short-term hyperglycemia (1 and 7 hrs), con-
tractile responses to norepinephrine (NE) were
unaffected in normal subjects using forearm
perfusion techniques (Houben et al., 1993, 1994).
In animal models, responses appear to vary in
different vascular beds; changes in endothelial
and/or vascular smooth muscle NO production
are thought to mediate, at least in part, the high
glucose effects on vascular reactivity (Bohlen
and Lash, 1993; Taylor and Poston, 1994;
Wascher et al., 1995; Cipolla et al., 1997). High
glucose concentrations have been reported to
decrease NO production by some investigators
(Gupta et al., 1992) but, others have shown
that high glucose concentrations enhance
NO production perhaps as a compensatory
mechanism for the associated excess super-
oxide radicals and oxidative stress (Graier et al.,
1996).
This investigation was conducted to examine
endothelial mediated relaxation to Ach and
contractile responses to NE and potassium chlo-
ride (KC1) in the tail artery of short-term (7-10
days) diabetic rats before physical glucose-
dependent changes of the arterial wall occur
since glucose-induced glycation and/or collagen
deposition may enhance arterial wall stiffness
and lead to erroneous conclusions regarding
endothelium-dependent effects. Thus, contrac-
tile properties of rings from both control and
diabetic animals incubated in vitro in high glu-
cose (HG) were compared to those incubated
in normal glucose buffer (NG). These experi-
ments were designed to simulate in vivo hy-
perglycemia and to test responses of diabetic
vessels when changed from a high glucose mi-
lieu to a normal glucose environment. L-glu-
cose was used to control for osmolar effect(s).
Ach-stimulated cGMP levels were measured as
a surrogate for vascular NO generation. Meas-
urement of antioxidants such as ascorbic acid
and glutathione were carried out to test whether
changes of cGMP levels are associated with
oxidative stress.
METHODS
Animals
The institutional Animal Investigations Com-
mittee approved all procedures in this study.
Male Sprague-Dawley rats (200-250gm) from
Charles River (Wilmington, MA) were housed
two per cage and given free access to rat chow
and water. Diabetes mellitus was induced by a
single intraperitoneal injection of streptozoto-
cin (SZ 65 mg/kg, Sigma, St. Louis. MO). Hyper-
glycemia was documented by monitoring tail
vein blood glucose. Under anesthesia (pento-
barbital 65 mg/kg), animals were sacrificed after
7-10 days of hyperglycemia by inducing pneu-ACETYLCHOLINE-STIMULATED CGMP 71
mothorax and blood samples were obtained for
serum glucose measurement (Yellow Springs
Instruments, Yellow Springs, OH). Age-matched
rats were used as controls.
Vascular Reactivity
Tail arteries were dissected free from connective
tissue and placed in ice-chilled normal buffer
containing MgSO4 1.20, NaC1 125, KC1 4.70,
KH2PO4 1.20, CaC12, 2H20 1.60, NaHCO3 84.01,
Dextrose 5 and NaEDTA 0.03mM. Arteries from
diabetic animals were divided into two groups:
one placed in normal buffer (diabetic NG) and
another kept in high glucose buffer (diabetic
HG) containing 20mM D-glucose with the same
ionic composition as normal buffer. A buffer
containing 5mM D-glucose + 15Mm L-glucose
(diabetic LG) was employed as osmotic control.
We chose L-glucose because it enters the cell
in a manner similar to D-glucose but does not
undergo any further metabolism, thus avoiding
cell shrinkage (Ibu and Short, 1986). Three
millimeter rings were suspended from isometric
force transducers (Gould instrument, Cleveland,
OH) in muscle baths containing the buffers
described above at 37C and aerated with a
mixture of 95% 02 and 5% CO2, pH 7.4. Rings
were stretched to I gm tension and allowed
to stabilize for 30min before adding agonists
(Walsh et al., 1996). The presence of intact endo-
thelium was confirmed in each ring by demon-
strating normal relaxation to Ach (10
-5M) after
submaximal contraction with KC1. Diabetic NG
rings were placed in buffer 2hours before
starting the experiment. In order to investigate
the effects of high glucose in vitro, agonist dose
responses were performed on arteries, from
control animals before and after 2-hour incuba-
tion with high glucose buffer (control HG).
Responses studied included relaxation to cumu-
lative doses of Ach (10-12-10-5M) after sub-
maximal contraction with KC1 (35mM, 80-90%
of maximal contractility), contraction to NE
(10-1-10-5M) and to KCL (10-45mM).
cGMP Assay
Aortae were used for measuring cGMP because
they provide a larger sample and respond
similarly to tail vasculature (Walsh et al., 1996).
Experiments were performed in conditions
similar to those for vascular reactivity (control
NG, control HG, diabetic NG, diabetic HG and
diabetic LG). The phosphodiesterase inhibitor
IBMX (1 mM) was added to the medium 30min
before obtaining basal samples. Ach was then ad-
ded at a dose of 10
-5mM and the reaction termi-
nated at 30, 120 and 300sec. To test if changes
in basal and/or stimulated cGMP levels were
NO mediated, these experiments were repeat-
ed in the presence of L-NAME (0.1mM for 30
min). All samples were snap frozen using dry
ice, homogenized and ether extracted on the day
of cGMP assay via ELISA (Cayman, Ann Arbor,
MI). Values were adjusted for the amount of
protein in the samples (Biorad, Hercules, PA).
Glutathione and Gllutathione
Disulfide Levels
GSH and GSSG were measured by high-perfor-
mance liquid chromatography (HPLC) accord-
ing to Bode (Rose and Bode, 1995). Samples
were sonicated in 1% picric acid, centrifuged
and the supernatant fractions assayed for GSH
or GSSG.
Statistical Analysis
Two-way analysis with Fisher’s protected least
significant difference and repeated measure
ANOVA were used to compare contractility
dose response curves when expressed as abso-
lute values (mg tension) and to compare Ach-sti-
mulated cGMP responses among vessels groups.
One-way ANOVA with Neuman-Keuls multi-
ple comparison test was used to study cGMP
responses to Ach in each group and to com-
pare basal cGMP levels among groups. EDs0 val-
ues for dose responses curves were calculated72 M. HAMATY et al.
using the Pharm C Program (Springer-Verlag,
New York, NY) and differences were deter-
mined by Student’s t-test, Differences in body
weight and serum glucose and GSH/GSS lev-
els were also evaluated using Student’s t-test,
Values in the text are given as mean +_ SEM
and P < 0.05 is considered significant.
RESULTS
betic HG vs. diabetic NG) (Fig. 1). Responses
to KC1 were higher in diabetic tail artery rings in
HG when compared to control in NG (maximal
contraction: control NG 967+108 vs. 13104-
117mg tension in diabetic HG, P<0.0001) with
no change in sensitivity. In contrast, responses to
KC1 in diabetic rings maintained in NG for
2 hours were identical to control (maximal con-
traction for diabetic NG 981 4- 73.7mg tension)
(Fig. 2).
Animal Profile
Short-term diabetes did not significantly affect
body weights (291 4-13 in diabetic animals vs.
283 4-11 gm in control) but serum glucose levels
were higher in the SZ injected animals (32.6 4- 0.9
vs. 11.9 4- 0.9mM, P < 0.0001).
Vascular Reactivity
Responses to NE and KCI: two-hour in vitro
incubation of tail artery rings with high glucose
buffer failed to alter contractile responses to ei-
ther NE or KC1 (data not shown). Maximal re-
sponses to NE were similar in all groups (Tab. I).
Responses in rings from diabetic animals in-
cubated in NG were attenuated at lower concen-
trations ofNE (10
-9M to 10-7M) when compared
to diabetic vessels maintained in HG or control
vessels in NG. This effect was significant only
between rings of diabetic animals inHG and dia-
betic in NG (P=0.014) when calculated over the
entire curve. However, sensitivity in these ves-
sels was significantly decreased, EDs0 was
doubled, compared with those kept in HG
and control vessels in NG (Tab.I) (P=0.005 for
control NG vs. diabetic NG, P=0.0003 for dia-
Relaxation to Ach
Preincubation in 20mM glucose for 2hrs did
not change KCl-induced submaximal contrac-
tion (748 4- 87 vs. 708 4- 83 mg in 5mM glucose).
Maximal relaxation to Ach was also similar in
both groups (controlNG 308 4- 41 vs. 320 4- 46mg
tension in control HG). As seen in Figure 3A, re-
laxation curves were significantly different (P
0.003 by two-way ANOVA). Rings exposed to
HG concentration relaxed to a greater extent
at low doses of Ach but sensitivity remained un-
impaired (EDs0: control NG 13.6 4- 4.1 x 10-s
vs. 12.94-6.9 x 10-8M in control HG, ED16: con-
trol NG 34 4- 8.7 x 10-1 vs. 25.9 4-11.3 x 10-1M
in control HG). Vessels from streptozotocin treat-
ed rats maintained in high glucose buffer (HG)
relaxed to Ach to the same extent as those of
control vessels in normal glucose buffer (NG).
On the other hand, in NG, maximal relaxation
remained similar to control but sensitivity to
Ach was decreased (P=0.002 for control NG vs.
diabetic NG, P=0.0009 for diabetic HG vs. dia-
betic NG) (Fig. 3B, Tab. I).
Diabetic rat vessel re6sponses to NE, KC1 and
Ach did not differ in hyperosmolar conditions
TABLE Relaxation and contractile responses in rat tail artery rings of short-term diabetic rats
Control NG Diabetic NG Diabetic HG
Submaximal contraction to KC1 (mg) 873 4- 86 792 4- 46 918 4-101
Maximal relaxation to Ach (mg) 298 4- 64 217 4- 46 278 4- 39
EDs0(M) 9.68 4-1.1 x 10
-8 26.5 4- 4.4 x 10-8* 10.5 q- 2.2 x 10
-8
Maximal contraction to NE(mg) 1300 +/- 138 1521 4-138 1420 4-109
ED50 (M) 7.6 4-1.6 x 10
-8 14.3 4-1.0 x 10-8** 6.15 4- 0.9 x 10
-8
P 0.002 vs. Control NG; P 0.009 vs. Diabetic HG.
P 0.005 vs. Control NG; P 0.0003 vs. Diabetic HG.ACETYLCHOLINE-STIMULATED CGMP 73
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FIGURE 1 Contractile responses to NE: Data are plotted as percent of maximal contraction. Attenuated responses in dia-
betic rings in NG compared with control in NG and diabetic HG with a significant change in ED50 (P =0.005, 0.0003, respec-
tively) but no difference between control in NG and diabetic in HG (control NG, n 5; diabetic NG, n 7; diabetic HG, n 5).
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FIGURE 2 Maximal contractility to KC1 is markedly enhanced in diabetic rings in HG compared with control vessels in
NG (P < 0.0001) while responses in diabetic in NG are identical to control in NG. Sensitivity to KC1 is unchanged in diabetic
vessels in HG (inset) (control NG, n 6; diabetic NG, n 7; diabetic HG, n 5).
(diabetic LG) from those seen in high D-glucose
(Tab. II) suggesting osmolality contributes to
these responses.
Aortic cGMP
Basal cGMP levels in endothelium-intact aortic
segments were lower only in vessels from74 M. HAMATY et al.
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FIGURE 3A Relaxation to Ach after submaximal contraction with KC1 in control rings in NG and HG: P 0.003 by two-way
ANOVA, no difference in ED50 or ED16 (control NG n=9, control HG n=9).
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FIGURE 3B Relaxation to Ach after submaximal contraction with KC1. Attenuated relaxation in diabetic vessels in NG with a
significant difference in EDs0 are seen when compared with control in NG and diabetic in HG (P 0.002, P 0.009 respectively)
while responses in control in NG and diabetic in HG are similar (control NG, n 9; diabetic NG, n 8 diabetic HG, n 7).
diabetic animals pre-incubated in NG when
compared with control in NG and diabetic rings
in high D-glucose or L-glucose buffer (Tab. III).
Ach effects on cGMP levels in control rings in
both NG and HG solutions were not significant,
but Ach caused a significant increase in cGMPACETYLCHOLINE-STIMULATED CGMP 75
TABLE II Relaxation and contractile responses in rat tail artery rings maintained in high D-glucose environment vs. high L-
glucose environment
Diabetic HG Diabetic LG
Submaximal contraction to KC1 873 4- 79mg 722 4-128mg
Maximal relaxation to Ach 195 4- 53mg 267 4-128mg
ED50 23.7 4- 2.2 x 10-sM 20.5 4- 2.6 x 10-sM
Maximal contraction to NE 1487 4-155mg 1562 4-134mg
EDs0 11.69 4- 3.7 x 10
-8M 9.7 4- 2.4 x 10
-8M
TABLE III Ach-stimulated cGMP responses in the aorta
Basal cGMP 30 sec 120 sec 300 sec
Control NG 12.8 4- 2.2 15.8 4- 3.2 13.6 4- 5.0 16.2 4- 5.5
Control HG 7.1 4- 2.7 32.6 4-10.2 36.2 4- 8.8 25.9 4- 8.7
Diabetic NG 2.8 4- 0.27* 9.3 4- 4.0 29.5 4-10.8"* 21.7 4- 6.8
Diabetic HG 14.4 4- 3.0 17.7 4- 5.7 42.9 4- 9.3** 32.5 4- 2.6
Diabetic LG 16.2 4- 2.9 45.1 4- 8.3 68.1 4-17.9
# 70.5 4-12.6
#
P < 0.05 compared with basal cGMP of control NG, diabetic HG and diabetic LG.
P < 0.05 compared with basal cGMP.
P < 0.01 compared with basal cGMP.
levels compared with baseline after 2min of
exposure to the drug in all three groups of
vessels from diabetic animal, i.e., in NG, HG and
LG. In the latter, the increase lasted up to
5minutes (Tab. III). Thus, short-term diabetes
resulted in enhanced cGMP responses to Ach
while hyprosmolality caused a combination of
enhancement and prolongation of the effect.
When Ach-stimulated cGMP levels were com-
pared among the groups, no difference between
control NG and diabetic rings in NG was seen
but continued exposure to high glucose (diabetic
HG) exaggerated the responses (P=0.02 vs.
control NG, P=0.043 vs. diabetic NG). Incubation
in a hyperosmolar buffer resulted in a greater
increase in cGMP in diabetic rings compared
with diabetic vessels kept in HG (P=0.0006)
and control vessels in NG (P <0.0001). These
data suggest that the D-glucose effects on Ach-
stimulated cGMP responses are not solely
dependent on its osmotic properties. When
control rings were pre-incubated in HG,
Ach-stimulated cGMP was increased but the
difference did not reach statistical signifi-
cance (P=0.059, two-way ANOVA). These Ach-
stimulated cGMP responses were mediated
by NO release since they were completely abo-
lished by L-NAME (data not shown).
Redox Status
These experiments were done on aortae from
control and diabetic animals only (n=10 for each)
because only arteries from diabetic animals
exhibited altered vascular reactivity and cGMP
responses. Samples were frozen immediately
after harvesting without any in vitro manipula-
tion of glucose concentration. Diabetic animals
had strikingly lower glutathione (GSH, control
0.74-0.2 vs. 0.384-0.03 in diabetics P<0.0001)
and higher oxidized glutahione (GSSG, control
0.154-0.04 vs. 0.17 4-0.02 in diabetics, P <0.0001)
indicative of augmented oxidative stress.
DISCUSSION
Our data show altered endothelium-dependent
function in early experimental insulinopenic
diabetes. Impairment of vascular relaxation
was evident when glucose concentrations were
reduced to an artificially normal value in vitro.76 M. HAMATY et al.
This impaired relaxation occurred despite a
compensatory increase in Ach-elicited cGMP
generation that brought cGMP to levels higher
than those seen in control rings. These data
suggest that impaired vascular relaxation to Ach
in diabetic rings in NG is caused by a mechan-
ism distal to and/or independent from NO-
mediated cGMP generation. High glucose
concentrations (both D-glucose and L-glucose)
caused exaggerated cGMP responses to Ach
under these conditions. Interestingly, cGMP re-
sponses to Ach in vessels from diabetic rats
maintained in a hyperosmolar buffer (L-glucose)
were much higher than those generated by ves-
sels maintained in a high D-glucose environ-
ment. This suggests that D-glucose effects on
Ach-stimulated cGMP are the net of multiple
factors: hyperosmolality may positively affect
cGMP accumulation while glucose metabolism
and resultant products may attenuate the osmo-
lar effect of glucose.
Hyperglycemia-mediated alterations in cGMP
responses to Ach may reflect changes in NO
production, action, free radical/NO scavenging
capacity and/or metabolism of cGMP. In results
similar to our own, Abiru et al., reported a shift
to the right in the concentration-response rela-
xation curve to Ach in mesenteric arteries of
diabetic rats. This was accompanied by lower
levels of both cAMP and cGMP (Abiru et al.,
1993). However, Graier et al., reported that
exposure to high glucose concentrations for 24
hours enhances bradykinin-induced-NO pro-
duction in cultured aortic endothelial cells
(Graier et al., 1996) as well as cGMP generation
(Graier et al., 1993) in association with greater
concentrations of superoxide radicals (Graier
et al., 1996). In our investigation, blockade of
NO formation by L-NAME abolished cGMP re-
sponses to Ach, supporting the conclusion that
differences in cGMP responses to Ach reflect
altered NO metabolism. However, we observed
augmented cGMP accumulation only in vessels
from diabetic animals while the increase in
cGMP responses in vessels from control rats
placed in high glucose buffer was marginal and
did not reach statistical significance. The differ-
ence between our results and those cited above
may reflect differences in vascular beds, the
short period (2 hrs) of high glucose exposure of
control vessels in our study, and possibly, a
greater ability of phosphodiesterase inhibitors to
prevent cGMP degradation in cultured cells in
contrast to vascular rings. Our results also show
greater oxidative stress in diabetic animals as
manifested by reduced glutathione (GSH) and
elevated oxidized glutathione (GSSG) content
in the vessels. These data are in agreement with
Graier’s report of a compensatory increase in
NO production in response to oxidative stress.
Although the effect(s) of glucose on cGMP phos-
phodiesterase has not been examined in the
vasculature, in other cells, glucose and hyper-
osmolality inhibit cGMP phosphodiesterase
activity and enhance cGMP levels (Oyama,
1996; Kuwayama et al., 1996).
Relaxation to Ach in diabetic vessels kept in
HG was not commensurate with the higher levels
of cGMP. This suggests that enhanced Ach-
stimulated cGMP generation compensates for a
defect distal to and/or independent from NO-
induced cGMP generation. Indeed, the capacity
of nitro-compounds to raise cGMP correlates
well with their potency to relax contracted
vessels (Popescu et al., 1985). Increased produc-
tion of constrictive prostaglandins (Tesfamariam
et al., 1990) and/or superoxide radical (Graier
et al., 1996) and decreased generation of endo-
thelium-dependent hyperpolarization factor
(Fukao et al., 1997) are other possibilities. Great-
er oxidative stress in vessels from diabetic ani-
mals supports the middle possibility. To date,
most in vitro contractile/relaxation studies of ves-
sels from diabetic animals have been performed
in normal glucose buffer. Of those that were
not, and in concert with results obtained in our
study, a high in vitro glucose milieu ameliorat-
ed the impaired sensitivity to Ach in aortae
from rats rendered diabetic for 8 weeks (Pieper
et al., 1997). Although others have reportedACETYLCHOLINE-STIMULATED CGMP 77
no improvement with up to 40mM glucose
(Archibald et al., 1996), these data underscore
the importance of maintaining a high glucose or
comparable osmolar environment during evalu-
ation of vessels from diabetic animals. Graier
et al. (1993, 1996) did not observe any L-glucose
effect on either endothelial NO or cGMP. This
could be explained by differences in experi-
mental conditions, i.e., cell culture versus ex vivo
studies, duration of exposure to L-glucose and,
in diabetic animals, previous in vivo exposure to
high glucose concentration as well as other meta-
bolic abnormalities encountered in diabetes.
Both the endothelium (Zvgmunt et al., 1995)
and VSMC (Yeh et al., 1996; Chaprie and Webb,
1993) contribute to NO production. Therefore,
basal cGMP levels reflect the end product of
endothelial and VSMC NO generation as well
as other factors that may alter cGMP metabo-
lism and guanylate cyclase activity. Although
our data show that the high glucose buffer did
not alter basal cGMP in vessels from control
animals, it normalized levels in aortae from
diabetic rats, an effect mimicked by the hyper-
osmolar effect of L-glucose. Since VSMC-derived
NO may act in an autocrine manner to limit con-
tractile activity (Yeh et al., 1996; Chaprie and
Webb, 1993), high basal cGMP levels in diabe-
tic aortic rings in HG may be the result of a
compensatory NO release from VSMC in re-
sponse to high glucose-induced increases in
vascular tone Again, these data underscore the
importance of the buffer glucose concentration
in interpreting vascular NO production in the
diabetic state.
In the vessels from diabetic rats, high glucose
augmented contractile responses to KC1 but not
to NE while exposure to normal glucose low-
ered responses to both: normalizing responses to
KC1 and significantly attenuating sensitivity to
NE. Thismaybe explainedby a glucose-mediated
action on voltage-dependent Ca
2+ influx and/
or mobilization of VSMC [Ca2+]i from inter-
nal stores. A high glucose environment in
VSMC has been reported to increase Ca
2+ influx
(Barbagallo et al., 1995), activate PKC by ele-
vated diacylglycerol levels (Williams, 1995;
Williams and Howard, 1994; Lee et al., 1989;
Inoguchi et al., 1992) and inhibit Na+-K+
ATPase activity (Gupta et al., 1992; Xia et al.,
1995). In addition, in cardiomyocytes, decreased
cellular GSH was shown to lower Na+-
K+ATPase activity (Haddock et al., 1995). The
data do not preclude the possibility of compen-
satory mechanisms that may mask abnormal
PKC and Na+-K+ ATPase activity, including in-
hibition of PKC and activation of Na+-K+
pump activity by the enhanced endothelial, and
probably VSMC, NO production (Minamino
et al., 1997; Nishizawa et al., 1996; Gupta et al.,
1994). On the other hand, oxidation of the thiol
group of L-type Ca
2+ channels activates Ca
2+
influx, at least in cardiomyocytes (Campbell
et al., 1996). Therefore, the increased oxida-
tive stress seen in our study may explain why
enhanced NO production prevented augment-
ed responses to NE but not to KC1 considering
that KCl-induced contraction is mainly mediat-
ed by voltage-dependent Ca
2+ influx (Himpens
et al., 1988), and may also explain why results
from cell culture experiments differ from ex vivo
ones. High glucose-induced impairment of endo-
thelial NO production has been proposed to de-
crease Na+-K+ ATPase (Gupta et al., 1992) but
the current data do not support this notion.
The effects of hyperosmolality on VSMC re-
main unclear and controversial (Barbagallo et al.,
1995; Williams and Howard 1994; Nielsen et al.,
1995; Soleimani et al., 1995). However, in this
investigation, in the tail artery and aorta, high
glucose had no effect on normal vessels, sug-
gesting that neither high glucose nor elevated
osmolality play a role in these vascular beds in
normal rats in the short term (2 hr). On the other
hand, maintaining a hyperosmolar environment
in vessels from diabetic rats resulted in contrac-
tile responses similar to those kept in a high D-
glucose concentration. Thus, contributing factors
in our short-term diabetic model, insulinope-
nia, and abnormal protein, lipid and glucose78 M. HAMATY et al.
metabolism may play a permissive role and al-
low expression of the high glucose and hy-
perosmolar effects on vascular contractility.
Many vascular pathologic changes may
impact on contractility/relaxation in long-term
diabetic animals. In our animal model, blood
pressure, heart rate and regional blood flow
were not different from controls (data not
shown). However, permanent changes in the
arterial wall, associated with longer duration of
diabetes mellitus, are unlikely to be respon-
sible for the vascular abnormalities observed in
these 7-10 days diabetic rats. Indeed, advanced
glycation end products are not seen before 3
weeks of SZ-induced diabetes (Rumble et al.,
1997). Although collagen deposition has been
reported after one week of SZ-induced diabetes
(Rumble et al., 1997), this is unlikely to mediate
impaired vascular relaxation since endothelium-
independent relaxation remains intact 8 weeks
after SZ treatment (Tesfamariam et al., 1990). On
the other hand, rapid glycation dependent on
reactive glucose metabolites in endothelial cells
may contribute to the overall oxidative stress
and vascular dysfunction seen in the short term.
In summary, our data indicate that: (1)
endothelium-dependent relaxation is altered in
the tail artery in the early stages of experimen-
tal diabetes; (2) aortic Ach-stimulated cGMP
responses in diabetes are enhanced; and (3)
some glucose effects on vascular reactivity are
mediated.by its osmotic properties; thus, in short-
term diabetic animals, hyperglycemia-enhanced
compensatory mechanisms to oxidative stress
aimed at maintaining vascular function are evi-
dent, at least in the tail artery and aorta, while
similar mechanisms are not activated by a 2hr
exposure of normal vessels to high glucose.
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